Thromboxane A 2 Receptors: Characterization and Regulation

[1]  P. Halushka,et al.  Testosterone increases thromboxane A2 receptors in cultured rat aortic smooth muscle cells. , 1991, Circulation research.

[2]  P. Halushka,et al.  Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat. , 1991, Biochemical pharmacology.

[3]  Ferenchick Gs.  Body weight and the sensitivity of blood pressure to sodium. , 1990 .

[4]  H. Arita,et al.  Biochemical characterization and comparison of rat thromboxane A2/prostaglandin H2 receptors in platelets and cultured aortic smooth muscle cells. , 1989, Biochemical pharmacology.

[5]  P. Halushka,et al.  Difluorothromboxane A2 and stereoisomers: stable derivatives of thromboxane A2 with differential effects on platelets and blood vessels. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[6]  K. J. Richter,et al.  Cardiomyopathy and Cerebrovascular Accident Associated With Anabolic-Androgenic Steroid Use. , 1988, The Physician and sportsmedicine.

[7]  J. Dolan,et al.  Evidence for homogeneity of thromboxane A2 receptor using structurally different antagonists. , 1988, European journal of pharmacology.

[8]  M. Frankle,et al.  Anabolic androgenic steroids and a stroke in an athlete: case report. , 1988, Archives of physical medicine and rehabilitation.

[9]  P. Halushka,et al.  Different pharmacologic activities for 13-azapinane thromboxane A2 analogs in platelets and blood vessels. , 1988, European journal of pharmacology.

[10]  P. Halushka,et al.  Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets. , 1985, The Journal of pharmacology and experimental therapeutics.

[11]  P. Halushka,et al.  Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors. , 1985, The Journal of pharmacology and experimental therapeutics.

[12]  P. Halushka,et al.  Further studies on the effects of epimers of thromboxane A2 antagonists on platelets and veins. , 1985, European journal of pharmacology.

[13]  D. Miller,et al.  Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogs. Evidence for selective blockade of thromboxane A2 responses. , 1985, Biochemical pharmacology.

[14]  P. Ramwell,et al.  Thromboxane agonism and antagonism in a mouse sudden death model. , 1983, The Journal of pharmacology and experimental therapeutics.

[15]  A. M. Lefer,et al.  Prevention of extension of ischaemic damage following acute myocardial ischaemia by dazoxiben, a new thromboxane synthetase inhibitor. , 1983, British journal of clinical pharmacology.

[16]  J. Karanian,et al.  EFFECT OF GENDER ON DEVELOPMENT AND DIURNAL RHYTHM OF PROSTAGLANDIN RECEPTORS IN RAT AORTA , 1981, British journal of pharmacology.

[17]  P. Ramwell,et al.  The Role of Gonadal Steroids in Arachidonate-Induced Mortality in Mice 1 , 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[18]  P. Needleman,et al.  Thromboxanes: selective biosynthesis and distinct biological properties. , 1976, Science.

[19]  S. Gershon,et al.  Similarities between behavioral and pharmacological actions of yohimbine and 5-hydroxytryptophan in the conscious dog. , 1970, European journal of pharmacology.

[20]  J. Vane,et al.  Release of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory Drugs , 1969, Nature.